Farlow M - Search Results

1

Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.

Poirier J, Delisle MC, Quirion R, Aubert I, Farlow M, Lahiri D, Hui S, Bertrand P, Nalbantoglu J, Gilfix BM, Gauthier S. Poirier J, et al. Among authors: farlow m. Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12260-4. doi: 10.1073/pnas.92.26.12260. Proc Natl Acad Sci U S A. 1995. PMID: 8618881 Free PMC article.

2

The cholinergic agonist carbachol reduces intracellular beta-amyloid precursor protein in PC 12 and C6 cells.

Lahiri DK, Nall C, Farlow MR. Lahiri DK, et al. Among authors: farlow mr. Biochem Int. 1992 Dec;28(5):853-60. Biochem Int. 1992. PMID: 1288495

3

Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans.

Hendrie HC, Hall KS, Hui S, Unverzagt FW, Yu CE, Lahiri DK, Sahota A, Farlow M, Musick B, Class CA, et al. Hendrie HC, et al. Among authors: farlow m. Ann Neurol. 1995 Jan;37(1):118-20. doi: 10.1002/ana.410370123. Ann Neurol. 1995. PMID: 7818244

4

Tacrine alters the secretion of the beta-amyloid precursor protein in cell lines.

Lahiri DK, Lewis S, Farlow MR. Lahiri DK, et al. Among authors: farlow mr. J Neurosci Res. 1994 Apr 15;37(6):777-87. doi: 10.1002/jnr.490370612. J Neurosci Res. 1994. PMID: 8046778

5

Differential effect of tacrine and physostigmine on the secretion of the beta-amyloid precursor protein in cell lines.

Lahiri DK, Farlow MR. Lahiri DK, et al. Among authors: farlow mr. J Mol Neurosci. 1996 Spring;7(1):41-9. doi: 10.1007/BF02736847. J Mol Neurosci. 1996. PMID: 8835781

6

Apolipoprotein E genotype and gender influence response to tacrine therapy.

Farlow MR, Lahiri DK, Poirier J, Davignon J, Hui S. Farlow MR, et al. Ann N Y Acad Sci. 1996 Dec 16;802:101-10. doi: 10.1111/j.1749-6632.1996.tb32603.x. Ann N Y Acad Sci. 1996. PMID: 8993489 Clinical Trial.

7

Effects of cholinesterase inhibitors on the secretion of beta-amyloid precursor protein in cell cultures.

Lahiri DK, Farlow MR, Nurnberger JI Jr, Greig NH. Lahiri DK, et al. Among authors: farlow mr. Ann N Y Acad Sci. 1997 Sep 26;826:416-21. doi: 10.1111/j.1749-6632.1997.tb48495.x. Ann N Y Acad Sci. 1997. PMID: 9329715

8

The effect of tacrine and leupeptin on the secretion of the beta-amyloid precursor protein in HeLa cells.

Lahiri DK, Farlow MR, Sambamurti K, Nall C. Lahiri DK, et al. Among authors: farlow mr. Life Sci. 1997;61(20):1985-92. doi: 10.1016/s0024-3205(97)00868-0. Life Sci. 1997. PMID: 9366505

9

Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease.

Farlow MR, Lahiri DK, Poirier J, Davignon J, Schneider L, Hui SL. Farlow MR, et al. Neurology. 1998 Mar;50(3):669-77. doi: 10.1212/wnl.50.3.669. Neurology. 1998. PMID: 9521254 Clinical Trial.

10

The secretion of amyloid beta-peptides is inhibited in the tacrine-treated human neuroblastoma cells.

Lahiri DK, Farlow MR, Sambamurti K. Lahiri DK, et al. Among authors: farlow mr. Brain Res Mol Brain Res. 1998 Nov 20;62(2):131-40. doi: 10.1016/s0169-328x(98)00236-8. Brain Res Mol Brain Res. 1998. PMID: 9813282

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

698 results

Search Page

Filters